Mostrar el registro sencillo del ítem

dc.contributor.authorPrado, Mayara Jorgenspt_BR
dc.contributor.authorSingh, Shripriyapt_BR
dc.contributor.authorBraun, Rodrigo Ligabuept_BR
dc.contributor.authorMeneghetti, Bruna Valandropt_BR
dc.contributor.authorSerrano, Thaiane Rispolipt_BR
dc.contributor.authorKopacek, Cristianept_BR
dc.contributor.authorMonteiro, Karina Mariantept_BR
dc.contributor.authorZaha, Arnaldopt_BR
dc.contributor.authorRossetti, Maria Lucia Rosapt_BR
dc.contributor.authorPandey, Amit V.pt_BR
dc.date.accessioned2023-11-14T03:24:50Zpt_BR
dc.date.issued2022pt_BR
dc.identifier.issn1422-0067pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/267104pt_BR
dc.description.abstractDeficiency of 21-hydroxylase enzyme (CYP21A2) represents 90% of cases in congenital adrenal hyperplasia (CAH), an autosomal recessive disease caused by defects in cortisol biosynthesis. Computational prediction and functional studies are often the only way to classify variants to under stand the links to disease-causing effects. Here we investigated the pathogenicity of uncharacterized variants in the CYP21A2 gene reported in Brazilian and Portuguese populations. Physicochemical alterations, residue conservation, and effect on protein structure were accessed by computational analysis. The enzymatic performance was obtained by functional assay with the wild-type and mutant CYP21A2 proteins expressed in HEK293 cells. Computational analysis showed that p.W202R, p.E352V, and p.R484L have severely impaired the protein structure, while p.P35L, p.L199P, and p.P433L have moderate effects. The p.W202R, p.E352V, p.P433L, and p.R484L variants showed residual 21OH activity consistent with the simple virilizing phenotype. The p.P35L and p.L199P variants showed partial 21OH efficiency associated with the non-classical phenotype. Additionally, p.W202R, p.E352V, and p.R484L also modified the protein expression level. We have determined how the selected CYP21A2 gene mutations affect the 21OH activity through structural and activity alteration contributing to the future diagnosis and management of CYP21A2 deficiency.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofInternational journal of molecular sciences. Basel. Vol. 23, no. 1 (Jan. 2022), e296, 19 p.pt_BR
dc.rightsOpen Accessen
dc.subjectTumor-derived exosomesen
dc.subjectHiperplasia adrenal congênitapt_BR
dc.subject21-hydroxylase deficiencyen
dc.subjectFunctional characterizationen
dc.titleCharacterization of mutations causing CYP21A2 deficiency in brazilian and portuguese populationspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001175277pt_BR
dc.type.originEstrangeiropt_BR


Ficheros en el ítem

Thumbnail
   

Este ítem está licenciado en la Creative Commons License

Mostrar el registro sencillo del ítem